Digipharm
DIGIPHARM
Digipharm brings together industry expertise, mature concepts and revolutionary blockchain technologies to facilitate the transformation of health care into a value-based approach.
The cost of spiral health combined with resource constraints has resulted in an unrelenting burden on the health system. Negotiations should be made, patients at risk of rejected innovative treatments and there are still barriers to reimbursement for producers.
Digipharm passed the limitations of infrastructure to enable the implementation of flexible value-based pricing agreements using smart contracts, the development of an unprecedented platform of evidence and the ability to reward patients for the contribution of their data.
Our vision
To pioneer the delivery of sustainable and value-based health services,
generation of innovative evidence and patient empowerment across the health care industry.
The Future of Health Care
- Values Based Care
- Innovative Price
- Generation of Pioneer Evidence
The Digipharm Difference
Elimination of Obstacles
While value-based health services provide solutions to the various problems faced by the health care system, the use of a broad-based value-based approach has been hampered by the limitations of current health information system infrastructure, administrative burden of implementation and fragmentation of health care delivery and patient outcome data.
Patient Empowerment
Digipharm is a strong believer in empowering patients with the care and ownership of their personal data. Patients will be given incentives to share and contribute their health-related data to inform decision-making and health-related research.
Blockchain Technology
The Digipharms solution will facilitate and accelerate paradigm shifts to value-based healthcare and patients using 'smart contracts' and blockchain technologies. Utilizing blockchain technology for the Digipharms platform promotes the development of an ubiquitous, transparent and secure decentralized health information infrastructure.
Our Excellence Solutions
- Speed up access to high cost therapies
- Encourage innovation
- Drastically reduce administrative costs
- Incentives for patients to contribute data
- Significant cost savings compared to conventional RWE sources
- Single platform for global proof
Our Team
Ahmed Abdulla
Founder/CEO
Girisha Fernando
Co-Founder/COO
Zach Daniels
CTO
Ralf Gerteis
Commercial Strategy
Alexander Sverdlov
Cybersecurity Strategy
Meredith Darden
Digital Marketing Lead
Alexey Popov
Web Development
Michael Gubert
UI/UX Design
Leon Rebolledo
Lead Architect
Rolf Günter
Legal Counsel
Bobby Kaura
Business Development
Dr. Mohamed Abdulla
Clinical Transformation
Dr. Hasham Al-Meshhedani
Patient Engagement
Ali Al-Sudani
Clinical Pharmacist
Dr. Rami Radwan
Clinical Relations
Peter Sandbach
Communications Director
Debra De Silva-Sun
HEOR & Pricing Analyst
Marko Granic
Graphic Designer
Our Advisors
Sven Möller
ICO Advisor
Swisscom Blockchain AG
Kamal Youssefi
Enterprise Blockchain Advisor
Swisscom Blockchain AG
Waldemar Scherer
Life Sciences Blockchain Advisor
Swisscom Blockchain AG
Sam Mantle
Health & Life Sciences Technology Advisor
Luxoft
Daniel Heller
PR Advisor
Partner, Farner Consulting AG
Claudio Staub
Co-Head Startup Communications
Farner Consulting AG
Anas Aman
Quality and Testing
IBM
Lloyd Jefferies
CRM Advisor
KPMG
Per-Olof Thuresson
Health Economist
Roche
Fadi Chehadah
Health Economist
NICE UK
Website: https://www.digipharm.ch/
Whitepaper: https://digipharm.ch/docs/DigipharmWP.pdf
Twitter : https://twitter.com/DigipharmTeam
Facebook: https://www.facebook.com/digipharmteam/
Medium: https://medium.com/@digipharm
===============================
Author: Mbladur
Bitcointalk Profile: https://bitcointalk.org/index.php?action=profile;u=1809638
Komentar
Posting Komentar